Search

Displaying results 6841 - 6850 of 10000 in total
  1. Drug

    Terbequinil

    go.drugbank.com/drugs/DB19516
    Experimental

    Terbequinil is a small molecule drug. The usage of the INN stem '-nil' in the name indicates that Terbequinil is a benzodiazepine receptor antagonist/agonist.

  2. Drug

    Lirequinil

    go.drugbank.com/drugs/DB19751
    Experimental

    Lirequinil is a small molecule drug. The usage of the INN stem '-nil' in the name indicates that Lirequinil is a benzodiazepine receptor antagonist/agonist.

  3. Drug

    Nitroxinil

    go.drugbank.com/drugs/DB20435
    Experimental

    Nitroxinil is a small molecule drug. The usage of the INN stem '-nil' in the name indicates that Nitroxinil is a benzodiazepine receptor antagonist/agonist.

  4. Drug

    Fampronil

    go.drugbank.com/drugs/DB20455
    Experimental

    Fampronil is a small molecule drug. The usage of the INN stem '-nil' in the name indicates that Fampronil is a benzodiazepine receptor antagonist/agonist.

  5. Drug

    Ontianil

    go.drugbank.com/drugs/DB20560
    Experimental

    Ontianil is a small molecule drug. The usage of the INN stem '-nil' in the name indicates that Ontianil is a benzodiazepine receptor antagonist/agonist.

  6. Drug

    Chlorazanil

    go.drugbank.com/drugs/DB19919
    Experimental

    Chlorazanil is a small molecule drug. The usage of the INN stem '-nil' in the name indicates that Chlorazanil is a benzodiazepine receptor antagonist/agonist.

  7. Drug

    Isothipendyl

    go.drugbank.com/drugs/DB08802
    Investigational

    Isothipendyl is an antihistamine and anticholinergic used as an antipruritic.

  8. Drug

    FK-960

    go.drugbank.com/drugs/DB06465
    Experimental

  9. Drug

    AG0302-COVID19

    go.drugbank.com/drugs/DB16435
    Investigational

    Sponsored by Anges, Inc. in Japan, the AG0302-COVID19 is a DNA-based vaccine that recently completed Phase I/II trials (NCT04527081)[A226813, L30548].

  10. Drug

    TP-271

    go.drugbank.com/drugs/DB15040
    Investigational

    TP-271 is under investigation in clinical trial NCT02724085 (A Phase 1 Study to Assess the Safety, Tolerability and PK of IV TP-271).